These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24403076)

  • 21. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY; Song IC; Kim J; Kwon GC
    Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.
    Zhang H; Means S; Schultz AR; Watanabe-Smith K; Medeiros BC; Bottomly D; Wilmot B; McWeeney SK; Kükenshöner T; Hantschel O; Tyner JW
    Cancer Res; 2017 Aug; 77(16):4258-4267. PubMed ID: 28652245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
    N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.
    Zhang H; Reister Schultz A; Luty S; Rofelty A; Su Y; Means S; Bottomly D; Wilmot B; McWeeney SK; Tyner JW
    Leukemia; 2017 Dec; 31(12):2752-2760. PubMed ID: 28439110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.
    Dwivedi P; Greis KD
    Exp Hematol; 2017 Feb; 46():9-20. PubMed ID: 27789332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced MAPK signaling is essential for CSF3R-induced leukemia.
    Rohrabaugh S; Kesarwani M; Kincaid Z; Huber E; Leddonne J; Siddiqui Z; Khalifa Y; Komurov K; Grimes HL; Azam M
    Leukemia; 2017 Aug; 31(8):1770-1778. PubMed ID: 28031554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
    Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
    Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
    [No Abstract]   [Full Text] [Related]  

  • 30. Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.
    Hinze A; Rinke J; Hochhaus A; Ernst T
    Ann Hematol; 2021 Feb; 100(2):581-584. PubMed ID: 32577845
    [No Abstract]   [Full Text] [Related]  

  • 31. Clonal evolution in a chronic neutrophilic leukemia patient.
    Zhang QG; Wang J; Gong WY; Jing QC
    Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
    Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
    J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for
    Ye P; Lin Q; Jin M; Gu X; Lu Y
    Turk J Haematol; 2023 Feb; 40(1):73-74. PubMed ID: 36510384
    [No Abstract]   [Full Text] [Related]  

  • 34. CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation.
    Sun H; Zhu Y; Li J; Zhao L; Yan Z; Zhang S
    Br J Haematol; 2024 Mar; 204(3):e31-e33. PubMed ID: 38262633
    [No Abstract]   [Full Text] [Related]  

  • 35. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
    Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Response of Chronic Neutrophilic Leukemia With CSF3R T618I, SETBP1, and ASXL1 Mutations After Decitabine Therapy.
    Cao S; Tao Q; Wang J; Zhang Q; Dong Y
    Am J Ther; 2024 Sep-Oct 01; 31(5):e550-e552. PubMed ID: 39292831
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia.
    Klimiankou M; Mellor-Heineke S; Zeidler C; Welte K; Skokowa J
    Ann N Y Acad Sci; 2016 Apr; 1370(1):119-25. PubMed ID: 27270496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of multiple myeloma and a CSF3R-mutated myeloid neoplasm.
    Stewart W; Hinton R; Bain BJ
    Am J Hematol; 2021 Nov; 96(11):1539-1540. PubMed ID: 34028856
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with CSF3R mutations.
    Chen X; Xu J; Fang F; Xu Z; Tan Y; Chang J; Muyey DM; Wang H
    Int J Lab Hematol; 2022 Apr; 44(2):364-370. PubMed ID: 34818692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Gotlib J; Deininger MMN; Oh ST; Cortes JE; Collins RH; Winton EF; Parker DR; Lee H; Reister A; Schultz ; Savage S; Stevens ; Brockett C; Subbiah N; Press RD; Raess PW; Cascio M; Dunlap J; Chen Y; Degnin C; Maxson JE; Tognon CE; Macey T; Druker BJ; Tyner JW
    J Clin Oncol; 2020 Apr; 38(10):1006-1018. PubMed ID: 31880950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.